Found: 4
Select item for more details and to access through your institution.
Legumain in the brain of animal models of Alzheimer's disease (AD) and its promise to be an intervention target for AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.051565
- By:
- Publication type:
- Article
Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer's disease.
- Published in:
- Journal of Nanobiotechnology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12951-021-00988-0
- By:
- Publication type:
- Article
Suppressing effect of the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger blocker CB-DMB on the growth of human glioblastoma cells.
- Published in:
- Journal of Shanghai Jiaotong University (Medical Science), 2021, v. 41, n. 6, p. 710, doi. 10.3969/j.issn.1674-8115.2021.06.002
- By:
- Publication type:
- Article
Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer's disease-related pathologies in a senescence-accelerated mouse model.
- Published in:
- Translational Neurodegeneration, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40035-021-00235-4
- By:
- Publication type:
- Article